Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Inclusion Criteria: * Symptoms compatible with SIBO * A positive breath test for either hydrogen predominant, methane predominant or mixed SIBO Exclusion Criteria: * History of diabetes mellitus, * Diarrhea predominant irritable bowel syndrome (IBS-D), * Symptomatic bowel obstruction, * Diverticulitis and/ or adhesions, * Autoimmune disorder, * Immunosuppression by medication or disease, * Pregnant or breast feeding, * The use of antibiotics, probiotics or prebiotics within the previous 30 days, * Known hypersensitivity to rifamycin, any of the other rifamycin class antimicrobial agents (e.g. rifaximin), or any of the components of AEMCOLO.